96 related articles for article (PubMed ID: 31283978)
1. Single-Fraction Stereotactic Radiosurgery Versus Hippocampal-Avoidance Whole Brain Radiation Therapy for Patients With 10 to 30 Brain Metastases: A Dosimetric Analysis.
Nguyen TK; Sahgal A; Detsky J; Soliman H; Myrehaug S; Tseng CL; Husain ZA; Carty A; Das S; Yang V; Lee Y; Sarfehnia A; Chugh BP; Yeboah C; Ruschin M
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):394-399. PubMed ID: 31283978
[TBL] [Abstract][Full Text] [Related]
2. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
Martinage G; Hong AM; Fay M; Thachil T; Roos D; Williams N; Lo S; Fogarty G
Radiat Oncol; 2018 Jul; 13(1):132. PubMed ID: 30029684
[TBL] [Abstract][Full Text] [Related]
3. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).
Grosu AL; Frings L; Bentsalo I; Oehlke O; Brenner F; Bilger A; Fennell JT; Rothe T; Schneider-Fuchs S; Graf E; Schmoor C; Beck J; Becker G; Bock M; Egger K; Urbach H; Lahmann C; Popp I
BMC Cancer; 2020 Jun; 20(1):532. PubMed ID: 32513138
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal sparing radiation therapy for brain metastases: treatment techniques and clinical implementation.
Woods K; Shen ZL; Xu Z; Zhang H; Natsuaki Y; Cheng K; Li V; Kim N; Ma L; Chang E
Chin Clin Oncol; 2023 Oct; 12(5):56. PubMed ID: 37964545
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery optimization with hippocampal-sparing in patients treated for brain metastases.
Burgess L; Nair V; Gratton J; Doody J; Chang L; Malone S
Phys Imaging Radiat Oncol; 2021 Jan; 17():106-110. PubMed ID: 33898788
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal Dosimetry and the Necessity of Hippocampal-Sparing in Gamma Knife Stereotactic Radiosurgery for Extensive Brain Metastases.
Riina MD; Stambaugh CK; Huber KE
Adv Radiat Oncol; 2020; 5(2):180-188. PubMed ID: 32280817
[TBL] [Abstract][Full Text] [Related]
7. Palliative whole brain radiation therapy: an international state of practice.
Keit E; Lee SF; Woodward M; Rembielak A; Shiue K; Desideri I; Oldenburger E; Bienz M; Rades D; Theodorou M; Agyeman MB; Yarney J; Bryant JM; Yu HM; Simone CB; Hoskin P; Johnstone PAS
Ann Palliat Med; 2023 Nov; 12(6):1155-1164. PubMed ID: 37731303
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Radiation Dosage to the Hippocampi during Treatment of Multiple Brain Metastases Using Gamma Knife Therapy.
Laskowski M; Błaszczyk B; Setlak M; Kuca M; Lech A; Kłos K; Rudnik A
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399534
[No Abstract] [Full Text] [Related]
9. New developments in intracranial stereotactic radiotherapy for metastases.
Pinkham MB; Whitfield GA; Brada M
Clin Oncol (R Coll Radiol); 2015 May; 27(5):316-23. PubMed ID: 25662094
[TBL] [Abstract][Full Text] [Related]
10. Treatment of brain metastases of renal cell cancer with combined hypofractionated stereotactic radiotherapy and whole brain radiotherapy with hippocampal sparing.
Vrána D; Študentová H; Matzenauer M; Vlachová Z; Cwiertka K; Gremlica D; Kalita O
Oncol Lett; 2016 Jun; 11(6):3777-3781. PubMed ID: 27313693
[TBL] [Abstract][Full Text] [Related]
11. Dose specification for hippocampal sparing whole brain radiotherapy (HS WBRT): considerations from the UK HIPPO trial QA programme.
Megias D; Phillips M; Clifton-Hadley L; Harron E; Eaton DJ; Sanghera P; Whitfield G
Br J Radiol; 2017 Mar; 90(1071):20160829. PubMed ID: 28059560
[TBL] [Abstract][Full Text] [Related]
12. Propensity score-matched analysis comparing hippocampus-avoidance whole-brain radiotherapy plus simultaneous integrated boost with hippocampus‑avoidance whole-brain radiotherapy alone for multiple brain metastases-a retrospective study in multiple institutions.
Wang X; Chen J; Lei Z; Chen H; Zhang Y; Liu G; Li S; Zheng Z; Wang H
BMC Cancer; 2023 Aug; 23(1):796. PubMed ID: 37620791
[TBL] [Abstract][Full Text] [Related]
13. Advancing Beyond the Hippocampus to Preserve Cognition for Patients With Brain Metastases: Dosimetric Results From a Phase 2 Trial of Memory-Avoidance Whole Brain Radiation Therapy.
Perlow HK; Nalin AP; Ritter AR; Addington M; Ward A; Liu M; Nappi C; Blakaj DM; Beyer SJ; Thomas EM; Grecula JC; Raval RR; Kotecha R; Boulter D; Dawson EL; Zoller W; Palmer JD
Adv Radiat Oncol; 2024 Feb; 9(2):101337. PubMed ID: 38405310
[TBL] [Abstract][Full Text] [Related]
14. Robust and optimal dose distribution for brain metastases with robotic radiosurgery system: recipe for an inflection point.
Hinoto R; Tsukamoto N; Eriguchi T; Kumada H; Sakae T
Biomed Phys Eng Express; 2024 Feb; 10(2):. PubMed ID: 38359444
[No Abstract] [Full Text] [Related]
15. Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001.
Cherng HR; Sun K; Bentzen S; Armstrong TS; Gondi V; Brown PD; Mehta M; Mishra MV
Neuro Oncol; 2024 May; 26(5):911-921. PubMed ID: 38069666
[TBL] [Abstract][Full Text] [Related]
16. Overview of dosimetric and biological perspectives on radiosurgery of multiple brain metastases in comparison with whole brain radiotherapy.
Xue J; LaCouture T; Grimm J; Goldman HW; Ibbott GS; Yorke E; Kubicek GJ
J Radiosurg SBRT; 2015; 3(4):271-279. PubMed ID: 29296410
[TBL] [Abstract][Full Text] [Related]
17. Whole-brain radiotherapy associated with structural changes resembling aging as determined by anatomic surface-based deep learning.
Rammohan N; Ho A; Besson P; Kruser TJ; Bandt SK
Neuro Oncol; 2023 Jul; 25(7):1323-1330. PubMed ID: 36734195
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive Effects Following Cranial Irradiation for Brain Metastases.
Pinkham MB; Sanghera P; Wall GK; Dawson BD; Whitfield GA
Clin Oncol (R Coll Radiol); 2015 Nov; 27(11):630-9. PubMed ID: 26119727
[TBL] [Abstract][Full Text] [Related]
19. Third whole-brain radiation therapy for multiple brain metastases. Should it be considered in selected patients?
Lapadula L; Piombino M; Bianculli A; Caivano R; Capobianco A; Cacciatore A; Cozzolino M; Oliviero C; D'andrea B; Mileo A; Leone A; Carbone F; Fochi NP; Landriscina M; Colamaria A; Giordano G
Cancer Radiother; 2023 Dec; 27(8):725-730. PubMed ID: 37777371
[TBL] [Abstract][Full Text] [Related]
20. The Hippocampus: A New Organ at Risk for Postoperative Radiation Therapy for Bucco-alveolar Cancer? A Dosimetric and Biological Analysis.
Nangia S; Singh M; Khosa R; Rout SK; Singh G; Oomen S
Adv Radiat Oncol; 2021; 6(3):100681. PubMed ID: 34195495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
